These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 3678062

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of concurrent monitoring and a preprinted note to modify prescribing of i.v. cimetidine and ranitidine in a teaching hospital.
    Dannenhoffer MA, Slaughter RL, Hunt SN.
    Am J Hosp Pharm; 1989 Aug; 46(8):1570-5. PubMed ID: 2773962
    [Abstract] [Full Text] [Related]

  • 4. Conversion of intravenous ranitidine to oral therapy.
    Baciewicz AM.
    DICP; 1991 Mar; 25(3):251-2. PubMed ID: 2028631
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intravenous cimetidine or two regimens of ranitidine to reduce fasting gastric acidity.
    Peterson WL, Richardson CT.
    Ann Intern Med; 1986 Apr; 104(4):505-7. PubMed ID: 3954278
    [Abstract] [Full Text] [Related]

  • 7. Risk for adverse events among patients receiving intravenous histamine2-receptor antagonists.
    Ben-Joseph R, Segal R, Russell WL.
    Ann Pharmacother; 1993 Dec; 27(12):1532-7. PubMed ID: 8305790
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of direct pharmacist intervention on conversion from parenteral to oral histamine H2-receptor antagonist therapy.
    Kirking DM, Svinte MK, Berardi RR, Cornish LA, Chaffee BW, Ryan ML.
    DICP; 1991 Jan; 25(1):80-4. PubMed ID: 1672572
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacin.
    Misiak PM, Eldon MA, Toothaker RD, Sedman AJ.
    J Clin Pharmacol; 1993 Jan; 33(1):53-6. PubMed ID: 8429114
    [Abstract] [Full Text] [Related]

  • 14. Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
    Knych HK, Stanley SD, Arthur RM, McKemie DS.
    J Vet Pharmacol Ther; 2017 Jan; 40(1):92-96. PubMed ID: 27292271
    [Abstract] [Full Text] [Related]

  • 15. Economic impact of inappropriate histamine2-receptor antagonist use.
    Wadibia EC, Lucas BD, Hilleman DE, Mooss AN.
    Clin Ther; 1997 Jan; 19(5):1085-91. PubMed ID: 9385495
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antiulcer prescribing program in a state correctional system.
    Keith MR, Cason DM, Helling DK.
    Ann Pharmacother; 1994 Jun; 28(6):792-6. PubMed ID: 7919571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.